Zimmer Biomet Holdings Gross Margin 2012-2026 | ZBH
Current and historical gross margin for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current gross profit margin for Zimmer Biomet Holdings as of June 30, 2026 is %.
| Zimmer Biomet Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $8.51B | $5.95B | 69.88% |
| 2026-03-31 | $8.41B | $5.89B | 70.03% |
| 2025-12-31 | $8.23B | $5.74B | 69.70% |
| 2025-09-30 | $8.01B | $5.72B | 71.45% |
| 2025-06-30 | $7.83B | $5.57B | 71.07% |
| 2025-03-31 | $7.70B | $5.47B | 71.06% |
| 2024-12-31 | $7.68B | $5.49B | 71.48% |
| 2024-09-30 | $7.60B | $5.45B | 71.78% |
| 2024-06-30 | $7.53B | $5.40B | 71.77% |
| 2024-03-31 | $7.45B | $5.36B | 71.88% |
| 2023-12-31 | $7.40B | $5.31B | 71.81% |
| 2023-09-30 | $7.28B | $5.21B | 71.62% |
| 2023-06-30 | $7.20B | $5.16B | 71.72% |
| 2023-03-31 | $7.11B | $5.09B | 71.58% |
| 2022-12-31 | $6.94B | $4.92B | 70.91% |
| 2022-09-30 | $6.89B | $4.86B | 70.47% |
| 2022-06-30 | $6.91B | $4.87B | 70.49% |
| 2022-03-31 | $6.89B | $4.87B | 70.63% |
| 2021-12-31 | $6.83B | $4.87B | 71.30% |
| 2021-09-30 | $6.24B | $4.47B | 71.69% |
| 2021-06-30 | $6.48B | $4.64B | 71.55% |
| 2021-03-31 | $5.94B | $4.17B | 70.19% |
| 2020-12-31 | $6.13B | $4.30B | 70.25% |
| 2020-09-30 | $7.07B | $5.00B | 70.81% |
| 2020-06-30 | $7.03B | $5.00B | 71.14% |
| 2020-03-31 | $7.79B | $5.61B | 71.94% |
| 2019-12-31 | $7.98B | $5.73B | 71.78% |
| 2019-09-30 | $7.93B | $5.67B | 71.57% |
| 2019-06-30 | $7.87B | $5.63B | 71.45% |
| 2019-03-31 | $7.89B | $5.64B | 71.49% |
| 2018-12-31 | $7.93B | $5.66B | 71.36% |
| 2018-09-30 | $7.93B | $5.65B | 71.25% |
| 2018-06-30 | $7.91B | $5.66B | 71.52% |
| 2018-03-31 | $7.85B | $5.65B | 72.02% |
| 2017-12-31 | $7.80B | $5.67B | 72.68% |
| 2017-09-30 | $7.73B | $5.57B | 72.03% |
| 2017-06-30 | $7.75B | $5.61B | 72.38% |
| 2017-03-31 | $7.74B | $5.48B | 70.88% |
| 2016-12-31 | $7.67B | $5.29B | 68.94% |
| 2016-09-30 | $7.61B | $5.18B | 68.05% |
| 2016-06-30 | $7.53B | $5.03B | 66.78% |
| 2016-03-31 | $6.77B | $4.61B | 68.11% |
| 2015-12-31 | $6.00B | $4.20B | 69.97% |
| 2015-09-30 | $5.29B | $3.84B | 72.71% |
| 2015-06-30 | $4.63B | $3.44B | 74.37% |
| 2015-03-31 | $4.65B | $3.42B | 73.65% |
| 2014-12-31 | $4.67B | $3.43B | 73.38% |
| 2014-09-30 | $4.69B | $3.44B | 73.27% |
| 2014-06-30 | $4.66B | $3.37B | 72.40% |
| 2014-03-31 | $4.65B | $3.37B | 72.50% |
| 2013-12-31 | $4.62B | $3.36B | 72.60% |
| 2013-09-30 | $4.56B | $3.32B | 72.74% |
| 2013-06-30 | $4.52B | $3.34B | 74.05% |
| 2013-03-31 | $4.47B | $3.34B | 74.73% |
| 2012-12-31 | $4.47B | $3.35B | 74.83% |
| 2012-09-30 | $4.46B | $3.33B | 74.66% |
| 2012-06-30 | $4.47B | $3.34B | 74.78% |
| 2012-03-31 | $4.48B | $3.35B | 74.74% |
| 2011-12-31 | $4.45B | $3.33B | 74.82% |
| 2011-09-30 | $4.42B | $3.33B | 75.29% |
| 2011-06-30 | $4.35B | $3.29B | 75.67% |
| 2011-03-31 | $4.27B | $3.25B | 76.06% |
| 2010-12-31 | $4.22B | $3.21B | 76.00% |
| 2010-09-30 | $4.19B | $3.18B | 75.84% |
| 2010-06-30 | $4.20B | $3.16B | 75.17% |
| 2010-03-31 | $4.17B | $3.14B | 75.28% |
| 2009-12-31 | $4.10B | $3.10B | 75.78% |
| 2009-09-30 | $4.02B | $3.06B | 76.09% |
| 2009-06-30 | $4.00B | $3.05B | 76.27% |
| 2009-03-31 | $4.06B | $3.08B | 75.98% |
| 2008-12-31 | $4.12B | $3.12B | 75.78% |
| 2008-09-30 | $4.17B | $3.16B | 75.77% |
| 2008-06-30 | $4.12B | $3.15B | 76.41% |
| 2008-03-31 | $4.01B | $3.08B | 76.92% |
| 2007-12-31 | $3.90B | $3.02B | 77.53% |
| 2007-09-30 | $3.76B | $2.93B | 77.91% |
| 2007-06-30 | $3.68B | $2.86B | 77.85% |
| 2007-03-31 | $3.59B | $2.79B | 77.77% |
| 2006-12-31 | $3.50B | $2.72B | 77.69% |
| 2006-09-30 | $3.41B | $2.65B | 77.80% |
| 2006-06-30 | $3.35B | $2.60B | 77.66% |
| 2006-03-31 | $3.32B | $2.58B | 77.76% |
| 2005-12-31 | $3.29B | $2.55B | 77.49% |
| 2005-09-30 | $3.24B | $2.50B | 77.04% |
| 2005-06-30 | $3.18B | $2.44B | 76.77% |
| 2005-03-31 | $3.07B | $2.32B | 75.55% |
| 2004-12-31 | $2.98B | $2.20B | 73.89% |
| 2004-09-30 | $2.88B | $2.07B | 71.78% |
| 2004-06-30 | $2.58B | $1.84B | 71.27% |
| 2004-03-31 | $2.25B | $1.62B | 71.68% |
| 2003-12-31 | $1.90B | $1.39B | 72.86% |
| 2003-09-30 | $1.57B | $1.18B | 75.46% |
| 2003-06-30 | $1.51B | $1.14B | 75.22% |
| 2003-03-31 | $1.44B | $1.08B | 74.93% |
| 2002-12-31 | $1.37B | $1.03B | 74.80% |
| 2002-09-30 | $1.32B | $0.98B | 74.37% |
| 2002-06-30 | $1.26B | $0.94B | 74.21% |
| 2002-03-31 | $1.21B | $0.89B | 73.51% |
| 2001-12-31 | $1.18B | $0.86B | 72.77% |
| 2001-09-30 | $1.12B | $0.81B | 72.39% |
| 2001-06-30 | $1.09B | $0.79B | 72.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.977B | $8.232B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |